ASGCT and JSGT Joint Position Statement on Human Genomic Editing

Affiliations

¹ Department of Pediatrics, Institute of Genomic Medicine, University of California San Diego School of Medicine, La Jolla, California, USA.
² Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
³ Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
⁴ Molecular and Cellular Therapy, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA.
⁵ University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁶ Division of Gene Therapy, Osaka University Graduate School of Medicine, Suita, Japan; President, JSGT.
⁷ Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, New York, USA; President, ASGCT. Electronic address: m-sadelain@ski.mskcc.org.

Theodore Friedmann et al. Mol Ther. 2015 Aug.

. 2015 Aug;23(8):1282.

doi: 10.1038/mt.2015.118.

¹ Department of Pediatrics, Institute of Genomic Medicine, University of California San Diego School of Medicine, La Jolla, California, USA.
² Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
³ Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
⁴ Molecular and Cellular Therapy, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA.
⁵ University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁶ Division of Gene Therapy, Osaka University Graduate School of Medicine, Suita, Japan; President, JSGT.
⁷ Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, New York, USA; President, ASGCT. Electronic address: m-sadelain@ski.mskcc.org.

No abstract available

MeSH terms